The varying clinical effectiveness of single, three and five intraarticular injections of platelet-rich plasma in knee osteoarthritis
Authors:
Open Access
- 8 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 19 (1) , 1-14
Abstract
Objective: To investigate the variations in clinical effectiveness among patients diagnosed with knee osteoarthritis who underwent intra-articular administration of platelet-rich plasma using single, triple, or quintuple injections. Methods: One hundred twenty patients with grade I-III knee osteoarthritis were randomly assigned to three groups: PRP1 group, who received a single injection of platelet-rich plasma; PRP3 group, who received three PRP injections one week apart; PRP5 group, who received five PRP injections one week apart. The patients’ conditions were evaluated using the Visual Analogue Scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index-VA3.1 version (WOMAC-VA3.1) at baseline and 6, 12, 24, and 52 weeks 52 weeks follow up. Results: Out of the total participants, 106 patients (30 males and 76 females) completed the study. The primary outcome measure, WOMAC pain score, registered significant improvements across all groups when compared to pre-treatment levels. However, the application of 3 and 5 injections of platelet-rich plasma was substantially more effective than that of a single injection in reducing knee pain and stiffness, as well as enhancing physical function in patients with knee osteoarthritis. No statistically discernable difference was observed between PRP3 and PRP5 at all follow-up intervals, and there was no discernable difference between 3 and 5 PRP injections either. Mild side effects occurred in all three groups. Conclusions: The administration of three or five injections of platelet-rich plasma is safe, substantially more effective than single injections, and leads to remarkable clinical improvement by significantly reducing knee pain, improving joint stiffness, and enhancing physical function in patients with grade I-III knee osteoarthritis. Furthermore, no significant difference was observed in the efficacy of three or five injections. Therefore, we recommend using three injections of PRP in the treatment of patients with knee osteoarthritis of grade I-III.Keywords
Funding Information
- Henan Science and Technology Project (232102310266)
- Henan Province Medical Science and Technology Research Program (SBGJ20210203)
This publication has 45 references indexed in Scilit:
- Single- and double-dose of platelet-rich plasmaversushyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trialWorld Journal of Orthopedics, 2019
- Blood-Derived Products for Tissue Repair/RegenerationInternational Journal of Molecular Sciences, 2019
- Effectiveness of platelet rich plasma in pain management of osteoarthritis knee: double blind, randomized comparative studyBrazilian Journal of Anesthesiology (English Edition), 2019
- Intraarticular injection of platelet-rich plasma in knee osteoarthritis: single versus triple application approach. Pilot study2019
- Comparison of Efficiency Between Corticosteroid and Platelet Rich Plasma Injection Therapies in Patients With Knee OsteoarthritisArchives of Rheumatology, 2018
- A Contemporary View of Platelet-Rich Plasma Therapies: Moving Toward Refined Clinical Protocols and Precise IndicationsRegenerative Medicine, 2018
- Some patients (and some of us) respond better to some biological therapies: the as yet unsolved conundrumJournal of Orthopaedics and Traumatology, 2018
- The Prevalence of Symptomatic Knee Osteoarthritis in China: Results From the China Health and Retirement Longitudinal StudyArthritis & Rheumatology, 2016
- Effectiveness of platelet-rich plasma in the treatment of moderate knee osteoarthritis: a randomized prospective studyJournal of Physical Therapy Science, 2015
- Accuracy of blind versus ultrasound‐guided suprapatellar bursal injectionJournal of Clinical Ultrasound, 2011